314 related articles for article (PubMed ID: 28777375)
1. Inhibition of Bcl-xL prevents pro-death actions of ΔN-Bcl-xL at the mitochondrial inner membrane during glutamate excitotoxicity.
Park HA; Licznerski P; Mnatsakanyan N; Niu Y; Sacchetti S; Wu J; Polster BM; Alavian KN; Jonas EA
Cell Death Differ; 2017 Nov; 24(11):1963-1974. PubMed ID: 28777375
[TBL] [Abstract][Full Text] [Related]
2. Bcl-xL inhibitor ABT-737 reveals a dual role for Bcl-xL in synaptic transmission.
Hickman JA; Hardwick JM; Kaczmarek LK; Jonas EA
J Neurophysiol; 2008 Mar; 99(3):1515-22. PubMed ID: 18160428
[TBL] [Abstract][Full Text] [Related]
3. ΔN-Bcl-xL, a therapeutic target for neuroprotection.
Park HA; Jonas EA
Neural Regen Res; 2017 Nov; 12(11):1791-1794. PubMed ID: 29239317
[TBL] [Abstract][Full Text] [Related]
4. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase.
Alavian KN; Li H; Collis L; Bonanni L; Zeng L; Sacchetti S; Lazrove E; Nabili P; Flaherty B; Graham M; Chen Y; Messerli SM; Mariggio MA; Rahner C; McNay E; Shore GC; Smith PJ; Hardwick JM; Jonas EA
Nat Cell Biol; 2011 Sep; 13(10):1224-33. PubMed ID: 21926988
[TBL] [Abstract][Full Text] [Related]
5. Bcl-x(L) blocks a mitochondrial inner membrane channel and prevents Ca2+ overload-mediated cell death.
Tornero D; Posadas I; Ceña V
PLoS One; 2011; 6(6):e20423. PubMed ID: 21674052
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial fragmentation and neuronal cell death in response to the Bcl-2/Bcl-x(L)/Bcl-w antagonist ABT-737.
Young KW; Piñón LG; Dhiraj D; Twiddy D; Macfarlane M; Hickman J; Nicotera P
Neuropharmacology; 2010 Jun; 58(8):1258-67. PubMed ID: 20307556
[TBL] [Abstract][Full Text] [Related]
7. Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization.
Buron N; Porceddu M; Brabant M; Desgué D; Racoeur C; Lassalle M; Péchoux C; Rustin P; Jacotot E; Borgne-Sanchez A
PLoS One; 2010 Mar; 5(3):e9924. PubMed ID: 20360986
[TBL] [Abstract][Full Text] [Related]
8. N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal death.
Ofengeim D; Chen YB; Miyawaki T; Li H; Sacchetti S; Flannery RJ; Alavian KN; Pontarelli F; Roelofs BA; Hickman JA; Hardwick JM; Zukin RS; Jonas EA
Nat Neurosci; 2012 Feb; 15(4):574-80. PubMed ID: 22366758
[TBL] [Abstract][Full Text] [Related]
9. A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2.
Renault TT; Dejean LM; Manon S
Mech Ageing Dev; 2017 Jan; 161(Pt B):201-210. PubMed ID: 27112371
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.
Abed MN; Abdullah MI; Richardson A
J Ovarian Res; 2016 Apr; 9():25. PubMed ID: 27080533
[TBL] [Abstract][Full Text] [Related]
11. BH3-mimetic ABT-737 induces strong mitochondrial membrane depolarization in platelets but only weakly stimulates apoptotic morphological changes, platelet shrinkage and microparticle formation.
Gyulkhandanyan AV; Mutlu A; Allen DJ; Freedman J; Leytin V
Thromb Res; 2014 Jan; 133(1):73-9. PubMed ID: 24268298
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells.
Lee SJ; Park HJ; Kim YH; Kim BY; Jin HS; Kim HJ; Han JH; Yim H; Jeong SY
Int J Mol Med; 2012 Aug; 30(2):443-50. PubMed ID: 22664653
[TBL] [Abstract][Full Text] [Related]
13. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
[TBL] [Abstract][Full Text] [Related]
14. Bcl-xL stimulates Bax relocation to mitochondria and primes cells to ABT-737.
Renault TT; Teijido O; Missire F; Ganesan YT; Velours G; Arokium H; Beaumatin F; Llanos R; Athané A; Camougrand N; Priault M; Antonsson B; Dejean LM; Manon S
Int J Biochem Cell Biol; 2015 Jul; 64():136-46. PubMed ID: 25862283
[TBL] [Abstract][Full Text] [Related]
15. The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells.
Allaman-Pillet N; Oberson A; Munier F; Schorderet DF
Ophthalmic Genet; 2013; 34(1-2):1-13. PubMed ID: 21955141
[TBL] [Abstract][Full Text] [Related]
16. The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production.
Bessou M; Lopez J; Gadet R; Deygas M; Popgeorgiev N; Poncet D; Nougarède A; Billard P; Mikaelian I; Gonzalo P; Rimokh R; Gillet G
Oncogene; 2020 Apr; 39(15):3056-3074. PubMed ID: 32066881
[TBL] [Abstract][Full Text] [Related]
17. Drp1 is dispensable for apoptotic cytochrome c release in primed MCF10A and fibroblast cells but affects Bcl-2 antagonist-induced respiratory changes.
Clerc P; Ge SX; Hwang H; Waddell J; Roelofs BA; Karbowski M; Sesaki H; Polster BM
Br J Pharmacol; 2014 Apr; 171(8):1988-99. PubMed ID: 24206264
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
19. ABT-737 sensitizes curcumin-induced anti-melanoma cell activity through facilitating mPTP death pathway.
Yu T; Chen C; Sun Y; Sun H; Li TH; Meng J; Shi X
Biochem Biophys Res Commun; 2015 Aug; 464(1):286-91. PubMed ID: 26116776
[TBL] [Abstract][Full Text] [Related]
20. Alpha-Tocotrienol Prevents Oxidative Stress-Mediated Post-Translational Cleavage of Bcl-xL in Primary Hippocampal Neurons.
Park HA; Mnatsakanyan N; Broman K; Davis AU; May J; Licznerski P; Crowe-White KM; Lackey KH; Jonas EA
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
